ASMTL and hepatocellular carcinoma: In conclusion, this research illustrated the participation of an ASMTL‐AS1/miR‐342‐3p/NLK/YAP signalling in reinforcing the malignancy of HCC cells, especially those in residual tumours after insufficient RFA.